SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030066
Filing Date
2019-08-07
Accepted
2019-08-07 16:11:31
Documents
58
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20190630.htm 10-Q 2681820
2 EX-10.2 ubx-ex102_103.htm EX-10.2 28910
3 EX-31.1 ubx-ex311_8.htm EX-31.1 18079
4 EX-31.2 ubx-ex312_7.htm EX-31.2 18062
5 EX-32.1 ubx-ex321_6.htm EX-32.1 14615
  Complete submission text file 0001564590-19-030066.txt   7800763

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ubx-20190630.xml EX-101.INS 1615790
7 XBRL TAXONOMY EXTENSION SCHEMA ubx-20190630.xsd EX-101.SCH 51660
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20190630_cal.xml EX-101.CAL 43854
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20190630_def.xml EX-101.DEF 168668
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20190630_lab.xml EX-101.LAB 378397
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20190630_pre.xml EX-101.PRE 297061
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 191005572
SIC: 2834 Pharmaceutical Preparations